Vispexia is a collagen—based bioengineered corneal implant for the treatment of severe stages of keratoconus. The implant solves the problem of a critical shortage of donor cornea, the only treatment option for keratoconus at the moment. Its production technology ensures high biocompatibility and long service life, and also has a platform potential (up to 10+ medical devices).